-
-
-
-
-
-
-
Genmab prices $2.5 billion in notes to fund Merus acquisition
-
-
-
-
-
-
-
Genmab A/S (GMAB) PT Raised to $49 at Truist Post MRUS Acquisition
-
-
-
-
-
-
-
Genmab Publishes 2024 Annual Report
-
-
-
-
-
-
-
Genmab A/S (GMAB) Completes Acquisition of ProfoundBio
-
-
-
-
-
-
-
AbbVie and Genmab Announce Topline Results for Epcoritamab (DuoBody®-CD3xCD20) from Phase 1/2 Trial in Patients with Relapsed/Refractory Large B-cell Lymphoma (LBCL)
-
-
-
-
-
-
-
Genmab (GMAB) and AbbVie (ABBV) Announce Broad Oncology Collaboration, Genmab to Receive Upfront Payment of $750M With Total Potential Milestones of Up to $3.15B
-
-
-
-
-
1,158,058 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

